{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:03:33Z","timestamp":1791813813497,"version":"4.3.4"},"reference-count":103,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T00:00:00Z","timestamp":1763251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCDD"],"abstract":"<jats:p>Dyslipidemia is a significant risk factor for atherosclerotic cardiovascular disease (ASCVD). Abnormal maternal lipid profiles in pregnancy are associated with pregnancy complications including preeclampsia, gestational diabetes, and pre-term delivery as well as increased ASCVD risk for both mother and child. Dyslipidemia management remains a central tenet for atherosclerotic cardiovascular disease prevention for women who are thinking about becoming pregnant or are already pregnant. Effective individualized guidance and multidisciplinary lifestyle\/dietary strategies, along with targeted pharmacological interventions, are required for the successful management of lipid disorders in pregnancy in order to optimize outcomes. This review discusses the physiological changes occurring in lipid metabolism during pregnancy and provides an overview of the current strategies for managing dyslipidemia during pregnancy, with a special focus on consideration of pharmacological therapy.<\/jats:p>","DOI":"10.3390\/jcdd12110445","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T12:33:04Z","timestamp":1763469184000},"page":"445","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Lipid Profile and Management of Dyslipidemias in Pregnancy"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3926-0304","authenticated-orcid":false,"given":"Constantine E.","family":"Kosmas","sequence":"first","affiliation":[{"name":"2nd Department of Cardiology, National & Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7349-0309","authenticated-orcid":false,"given":"Loukianos S.","family":"Rallidis","sequence":"additional","affiliation":[{"name":"2nd Department of Cardiology, National & Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Hoursalas","sequence":"additional","affiliation":[{"name":"School of Medicine, European University Cyprus, Nicosia 2404, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni-Angeliki","family":"Zoumi","sequence":"additional","affiliation":[{"name":"Guy\u2019s & St. Thomas\u2019 NHS Foundation Trust, London SE1 9RT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7045-1323","authenticated-orcid":false,"given":"Christina E.","family":"Kostara","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Chemistry, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Liu, T., Zhao, D., and Qi, Y. (2022). Global Trends in the Epidemiology and Management of Dyslipidemia. J. Clin. Med., 11.","DOI":"10.3390\/jcm11216377"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Formisano, E., Proietti, E., Perrone, G., Demarco, V., Galoppi, P., Stefanutti, C., and Pisciotta, L. (2024). Characteristics, Physiopathology and Management of Dyslipidemias in Pregnancy: A Narrative Review. Nutrients, 16.","DOI":"10.3390\/nu16172927"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Schienkiewitz, A., Truthmann, J., Ernert, A., Wiegand, S., Schwab, K.O., and Scheidt-Nave, C. (2019). Age, maturation and serum lipid parameters: Findings from the German Health Survey for Children and Adolescents. BMC Public Health, 19.","DOI":"10.1186\/s12889-019-7901-z"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"100333","DOI":"10.1016\/j.ajpc.2022.100333","article-title":"Evaluation and management of blood lipids through a woman\u2019s life cycle","volume":"10","author":"Sharma","year":"2022","journal-title":"Am. J. Prev. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/aje\/kwu145","article-title":"Maternal hyperlipidemia and the risk of preeclampsia: A meta-analysis","volume":"180","author":"Spracklen","year":"2014","journal-title":"Am. J. Epidemiol."},{"key":"ref_6","first-page":"883","article-title":"Pregnancy-related cardiovascular risk indicators: Primary care approach to postpartum management and prevention of future disease","volume":"65","author":"Graves","year":"2019","journal-title":"Can. Fam. Physician Med. Fam. Can."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0140-6736(99)02131-5","article-title":"Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study","volume":"354","author":"Napoli","year":"1999","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/jamacardio.2015.0304","article-title":"Association of Maternal Prepregnancy Dyslipidemia with Adult Offspring Dyslipidemia in Excess of Anthropometric, Lifestyle, and Genetic Factors in the Framingham Heart Study","volume":"1","author":"Mendelson","year":"2016","journal-title":"JAMA Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/eurjpc\/zwab152","article-title":"Maternal hypercholesterolaemia during pregnancy affects severity of myocardial infarction in young adults","volume":"29","author":"Cacciatore","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","article-title":"2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy","volume":"39","author":"Bauersachs","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_11","unstructured":"Authors\/Task Force Members, ESC Committee for Practice Guidelines (CPG), and ESC National Cardiac Societies (2019). 2019 ESC\/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis, 290, 140\u2013205."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"oeae032","DOI":"10.1093\/ehjopen\/oeae032","article-title":"Dyslipidaemia management in pregnant patients: A 2024 update","volume":"4","author":"Lewek","year":"2024","journal-title":"Eur. Heart J. Open"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/1389201015666140330192345","article-title":"Lipid metabolism during pregnancy and its implications for fetal growth","volume":"15","author":"Herrera","year":"2014","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0002-9378(11)91714-1","article-title":"Effect of fat and fat-free mass deposition during pregnancy on birth weight","volume":"167","author":"Villar","year":"1992","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.physbeh.2007.04.012","article-title":"Neuroendocrine mechanisms of change in food intake during pregnancy: A potential role for brain oxytocin","volume":"91","author":"Douglas","year":"2007","journal-title":"Physiol. Behav."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1210\/jcem-67-2-341","article-title":"Role of gestational hormones in the induction of insulin resistance","volume":"67","author":"Ryan","year":"1988","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/0002-9378(88)90193-7","article-title":"Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancy","volume":"158","author":"Herrera","year":"1988","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_18","first-page":"E930","article-title":"Lipoprotein lipase and hormone-sensitive lipase activity and mRNA in rat adipose tissue during pregnancy","volume":"266","author":"Holm","year":"1994","journal-title":"Am. J. Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"834","DOI":"10.2337\/diabetes.48.4.834","article-title":"Effect of insulin on fat metabolism during and after normal pregnancy","volume":"48","author":"Sivan","year":"1999","journal-title":"Diabetes"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1210\/jcem.82.12.4472","article-title":"Multiple beneficial effects of estrogen on lipoprotein metabolism","volume":"82","author":"Knopp","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0009-9120(94)90013-2","article-title":"Changes in cholesteryl ester transfer protein activity during normal gestation and postpartum","volume":"27","author":"Iglesias","year":"1994","journal-title":"Clin. Biochem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0022-2275(20)37617-3","article-title":"Longitudinal study on lipoprotein profile, high density lipoprotein subclass, and postheparin lipases during gestation in women","volume":"37","author":"Alvarez","year":"1996","journal-title":"J. Lipid Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Bever, A.M., Mumford, S.L., Schisterman, E.F., Sjaarda, L., Perkins, N.J., Gerlanc, N., DeVilbiss, E.A., Silver, R.M., Kim, K., and Nobles, C.J. (2020). Maternal preconception lipid profile and gestational lipid changes in relation to birthweight outcomes. Sci. Rep., 10.","DOI":"10.1038\/s41598-019-57373-z"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e4048","DOI":"10.1210\/clinem\/dgac442","article-title":"Associations Between Maternal Lipid Blood Levels at the 13th Week of Pregnancy and Offspring\u2019s Adiposity at Age 11\u201312 Years","volume":"107","author":"Baas","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Waage, C.W., Mdala, I., Stigum, H., Jenum, A.K., Birkeland, K.I., Shakeel, N., Michelsen, T.M., Richardsen, K.R., and Sletner, L. (2022). Lipid and lipoprotein concentrations during pregnancy and associations with ethnicity. BMC Pregnancy Childbirth, 22.","DOI":"10.1186\/s12884-022-04524-2"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1093\/eurheartj\/ehad472","article-title":"Women, lipids, and atherosclerotic cardiovascular disease: A call to action from the European Atherosclerosis Society","volume":"44","author":"Tokgozoglu","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Wu, L., Wu, Q., Li, Q., Cao, S., Zhang, Y., Liu, Y., and Qin, X. (2022). Consecutive reference intervals for biochemical indices related to serum lipid levels and renal function during normal pregnancy. BMC Pregnancy Childbirth, 22.","DOI":"10.1186\/s12884-022-04960-0"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1515\/CCLM.2010.033","article-title":"Laboratory reference intervals during pregnancy, delivery and the early postpartum period","volume":"48","author":"Klajnbard","year":"2010","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"482.e1","DOI":"10.1016\/j.ajog.2009.05.032","article-title":"Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: A population-based study","volume":"201","author":"Wiznitzer","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e884","DOI":"10.1161\/CIR.0000000000000772","article-title":"Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association","volume":"141","author":"Mehta","year":"2020","journal-title":"Circulation"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e028626","DOI":"10.1161\/JAHA.122.028626","article-title":"Feasibility of Lipid Screening During First Trimester of Pregnancy to Identify Women at Risk of Severe Dyslipidemia","volume":"12","author":"Golwala","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/humupd\/dmp025","article-title":"Role of micronutrients in the periconceptional period","volume":"16","author":"Cetin","year":"2010","journal-title":"Hum. Reprod. Update"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S1472-6483(10)61178-9","article-title":"Diet around conception and during pregnancy\u2014Effects on fetal and neonatal outcomes","volume":"12","author":"Kind","year":"2006","journal-title":"Reprod. Biomed. Online"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1218S","DOI":"10.1093\/ajcn\/71.5.1218s","article-title":"Physiology of pregnancy and nutrient metabolism","volume":"71","author":"King","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1007\/s10995-013-1401-z","article-title":"US provider-reported diet and physical activity counseling to pregnant and non-pregnant women of childbearing age during preventive care visits","volume":"18","author":"Yamamoto","year":"2014","journal-title":"Matern. Child. Health J."},{"key":"ref_38","unstructured":"European Food Information, Eufic (2025, July 19). Healthy Pregnancy: What Foods to Eat When Pregnant. Last Updated 01 August 2021. Available online: https:\/\/www.eufic.org\/en\/healthy-living\/article\/healthy-pregnancy-what-foods-to-eat-when-pregnant."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Amati, F., Hassounah, S., and Swaka, A. (2019). The Impact of Mediterranean Dietary Patterns During Pregnancy on Maternal and Offspring Health. Nutrients, 11.","DOI":"10.3390\/nu11051098"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e13454","DOI":"10.1111\/mcn.13454","article-title":"Association of Mediterranean diet adherence during pregnancy with maternal and neonatal lipid, glycemic and inflammatory markers: The GESTAFIT project","volume":"19","author":"Migueles","year":"2023","journal-title":"Matern. Child. Nutr."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Melero, V., Arnoriaga, M., Barabash, A., Valerio, J., Del Valle, L., Martin O\u2019Connor, R., de Miguel, M.P., Diaz, J.A., Familiar, C., and Moraga, I. (2023). An Early Mediterranean-Based Nutritional Intervention during Pregnancy Reduces Metabolic Syndrome and Glucose Dysregulation Rates at 3 Years Postpartum. Nutrients, 15.","DOI":"10.3390\/nu15143252"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Flor-Alemany, M., Migueles, J.H., Alemany-Arrebola, I., Aparicio, V.A., and Baena-Garcia, L. (2022). Exercise, Mediterranean Diet Adherence or Both during Pregnancy to Prevent Postpartum Depression-GESTAFIT Trial Secondary Analyses. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph192114450"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Eckl, M.R., Brouwer-Brolsma, E.M., and Kupers, L.K. (2021). Maternal Adherence to the Mediterranean Diet during Pregnancy: A Review of Commonly Used a priori Indexes. Nutrients, 13.","DOI":"10.3390\/nu13020582"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e022589","DOI":"10.1161\/JAHA.121.022589","article-title":"Mediterranean-Style Diet and Risk of Preeclampsia by Race in the Boston Birth Cohort","volume":"11","author":"Minhas","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Dai, F.C., Wang, P., Li, Q., Zhang, L., Yu, L.J., Wu, L., Tao, R.X., and Zhu, P. (2022). Mediterranean diet during pregnancy and infant neurodevelopment: A prospective birth cohort study. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.1078481"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"102551","DOI":"10.1016\/j.ctim.2020.102551","article-title":"Effects of the Dietary Approaches to Stop Hypertension (DASH) on Pregnancy\/Neonatal Outcomes and Maternal Glycemic Control: A Systematic Review and Meta-analysis of Randomized Clinical Trials","volume":"54","author":"Li","year":"2020","journal-title":"Complement. Ther. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1136\/bjsports-2018-099697","article-title":"Impact of prenatal exercise on both prenatal and postnatal anxiety and depressive symptoms: A systematic review and meta-analysis","volume":"52","author":"Davenport","year":"2018","journal-title":"Br. J. Sports Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/bjsports-2018-099773","article-title":"Prenatal exercise is not associated with fetal mortality: A systematic review and meta-analysis","volume":"53","author":"Davenport","year":"2019","journal-title":"Br. J. Sports Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1136\/bjsports-2018-099355","article-title":"Prenatal exercise for the prevention of gestational diabetes mellitus and hypertensive disorders of pregnancy: A systematic review and meta-analysis","volume":"52","author":"Davenport","year":"2018","journal-title":"Br. J. Sports Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1136\/bjsports-2018-099836","article-title":"Impact of prenatal exercise on neonatal and childhood outcomes: A systematic review and meta-analysis","volume":"52","author":"Davenport","year":"2018","journal-title":"Br. J. Sports Med."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"(1984). The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA, 251, 351\u2013364.","DOI":"10.1001\/jama.1984.03340270029025"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Triglyceride Coronary Disease Genetics Consortium, Emerging Risk Factors Collaboration, Sarwar, N., Sandhu, M.S., Ricketts, S.L., Butterworth, A.S., Di Angelantonio, E., Boekholdt, S.M., Ouwehand, W., and Watkins, H. (2010). Triglyceride-mediated pathways and coronary disease: Collaborative analysis of 101 studies. Lancet, 375, 1634\u20131639.","DOI":"10.1016\/S0140-6736(10)60545-4"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1161\/01.CIR.98.19.2088","article-title":"Mechanism of action of fibrates on lipid and lipoprotein metabolism","volume":"98","author":"Staels","year":"1998","journal-title":"Circulation"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0022-2275(20)30189-9","article-title":"Opposite metabolic response to fenofibrate treatment in pregnant and virgin rats","volume":"43","author":"Soria","year":"2002","journal-title":"J. Lipid Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1345\/aph.1Q626","article-title":"Use of fenofibrate during the first trimester of unplanned pregnancy in a patient with hypertriglyceridemia","volume":"46","author":"Sunman","year":"2012","journal-title":"Ann. Pharmacother."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/AOG.0b013e31820755b5","article-title":"Hyperlipidemia-associated pancreatitis in pregnancy managed with fenofibrate","volume":"117","author":"Whitten","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10654-013-9762-6","article-title":"Cardiovascular disease risk in women with pre-eclampsia: Systematic review and meta-analysis","volume":"28","author":"Brown","year":"2013","journal-title":"Eur. J. Epidemiol."},{"key":"ref_58","first-page":"211","article-title":"Treatment of Severe Hypertriglyceridemia During Pregnancy With High Doses of Omega-3 Fatty Acid and Plasmapheresis","volume":"7","author":"Nguyen","year":"2021","journal-title":"AACE Clin. Case Rep."},{"key":"ref_59","first-page":"CD003402","article-title":"Omega-3 fatty acid addition during pregnancy","volume":"11","author":"Middleton","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e664","DOI":"10.1016\/j.jacl.2024.05.005","article-title":"Dyslipidemia management in women of reproductive potential: An Expert Clinical Consensus from the National Lipid Association","volume":"18","author":"Agarwala","year":"2024","journal-title":"J. Clin. Lipidol."},{"key":"ref_61","first-page":"196","article-title":"Hyperlipidaemia and severe hypertriglyceridaemia in pregnancy","volume":"25","author":"Bashir","year":"2023","journal-title":"Obs. Gynecol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/tera.1420280316","article-title":"Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase","volume":"28","author":"Minsker","year":"1983","journal-title":"Teratology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/tera.1420500604","article-title":"Developmental toxicity of the HMG-CoA reductase inhibitor, atorvastatin, in rats and rabbits","volume":"50","author":"Dostal","year":"1994","journal-title":"Teratology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0890-6238(96)00130-X","article-title":"Postmarketing surveillance of lovastatin and simvastatin exposure during pregnancy","volume":"10","author":"Manson","year":"1996","journal-title":"Reprod. Toxicol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJM200404083501524","article-title":"Central nervous system and limb anomalies in case reports of first-trimester statin exposure","volume":"350","author":"Edison","year":"2004","journal-title":"N. Eng. J. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/bdra.20181","article-title":"Pregnancy outcomes after maternal exposure to simvastatin and lovastatin","volume":"73","author":"Pollack","year":"2005","journal-title":"Birth Defects Res. Part A Clin. Mol. Teratol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1002\/ajmg.a.32493","article-title":"Maternal exposure to statins and risk for birth defects: A case-series approach","volume":"146A","author":"Petersen","year":"2008","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.reprotox.2008.06.009","article-title":"Prenatal exposure to HMG-CoA reductase inhibitors: Effects on fetal and neonatal outcomes","volume":"26","author":"Taguchi","year":"2008","journal-title":"Reprod. Toxicol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/1471-0528.12066","article-title":"Pregnancy outcome following maternal exposure to statins: A multicentre prospective study","volume":"120","author":"Winterfeld","year":"2013","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"h1035","DOI":"10.1136\/bmj.h1035","article-title":"Statins and congenital malformations: Cohort study","volume":"350","author":"Bateman","year":"2015","journal-title":"BMJ"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2125.2007.02905.x","article-title":"Risk of congenital anomalies in pregnant users of statin drugs","volume":"64","author":"Ofori","year":"2007","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/pds.1995","article-title":"Linking a pharmaceutical claims database with a birth defects registry to investigate birth defect rates of suspected teratogens","volume":"19","author":"Colvin","year":"2010","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIRCULATIONAHA.110.990929","article-title":"Pregnancy outcomes in familial hypercholesterolemia: A registry-based study","volume":"124","author":"Toleikyte","year":"2011","journal-title":"Circulation"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.atherosclerosis.2018.05.038","article-title":"Statins and other lipid-lowering therapy and pregnancy outcomes in homozygous familial hypercholesterolaemia: A retrospective review of 39 pregnancies","volume":"277","author":"Botha","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S1701-2163(15)30565-X","article-title":"The fetal safety of statins: A systematic review and meta-analysis","volume":"36","author":"Zarek","year":"2014","journal-title":"J. Obstet. Gynaecol. Can. JOGC J. D\u2019obstetrique Et Gynecol. Du. Can. JOGC"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jacl.2016.07.002","article-title":"The risks of statin use in pregnancy: A systematic review","volume":"10","author":"Karalis","year":"2016","journal-title":"J. Clin. Lipidol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1111\/bcp.15423","article-title":"Pregnancy outcomes following maternal exposure to statins: A systematic review and meta-analysis","volume":"88","author":"Karadas","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"720.e1","DOI":"10.1016\/j.ajog.2015.12.038","article-title":"Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: A pilot randomized controlled trial","volume":"214","author":"Costantine","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"666.e1","DOI":"10.1016\/j.ajog.2021.05.018","article-title":"A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia","volume":"225","author":"Costantine","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e0172174","DOI":"10.1371\/journal.pone.0172174","article-title":"The effects of pravastatin on the normal human placenta: Lessons from ex-vivo models","volume":"12","author":"Balan","year":"2017","journal-title":"PLoS ONE"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1161\/CIRCULATIONAHA.106.660134","article-title":"Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1","volume":"115","author":"Cudmore","year":"2007","journal-title":"Circulation"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/HYPERTENSIONAHA.115.05445","article-title":"Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia","volume":"66","author":"Brownfoot","year":"2015","journal-title":"Hypertension"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.preghy.2020.03.004","article-title":"Pravastatin as the statin of choice for reducing pre-eclampsia-associated endothelial dysfunction","volume":"20","author":"Beard","year":"2020","journal-title":"Pregnancy Hypertens."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Meszaros, B., Veres, D.S., Nagyistok, L., Somogyi, A., Rosta, K., Herold, Z., Kukor, Z., and Valent, S. (2022). Pravastatin in preeclampsia: A meta-analysis and systematic review. Front. Med., 9.","DOI":"10.3389\/fmed.2022.1076372"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/CIRCULATIONAHA.121.053963","article-title":"Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia","volume":"144","author":"Dobert","year":"2021","journal-title":"Circulation"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/CIRCULATIONAHA.121.058983","article-title":"Statin Use in Pregnancy: Is It Time For a Paradigm Shift?","volume":"145","author":"Mauricio","year":"2022","journal-title":"Circulation"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1073\/pnas.0335507100","article-title":"The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation","volume":"100","author":"Seidah","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jacl.2017.05.001","article-title":"Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid Association","volume":"11","author":"Orringer","year":"2017","journal-title":"J. Clin. Lipidol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MOL.0000000000000877","article-title":"Inclisiran: Present and future perspectives of a new effective LDL cholesterol-lowering agent","volume":"34","author":"Giordano","year":"2023","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/bdr2.1930","article-title":"Exposure to alirocumab during the first trimester of pregnancy: A case report","volume":"113","author":"Vuignier","year":"2021","journal-title":"Birth Defects Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/jog.15813","article-title":"PCSK9 inhibitor use during pregnancy in a case of familial hypercholesterolemia complicated with coronary artery disease","volume":"50","author":"Suzuki","year":"2024","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/eurjpc\/zwad402","article-title":"Genetically proxied low-density lipoprotein cholesterol lowering via PCSK9-inhibitor drug targets and risk of congenital malformations","volume":"31","author":"Ardissino","year":"2024","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/eurjpc\/zwae018","article-title":"The use of PCSK9 inhibitors should be avoided during pregnancy: Results from a Mendelian randomization study","volume":"31","author":"Efird","year":"2024","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/cpt.3269","article-title":"Safety of Monoclonal Antibodies Inhibiting PCSK9 in Pregnancy: Disproportionality Analysis in VigiBase(R)","volume":"116","author":"Noseda","year":"2024","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0002-9149(94)90461-8","article-title":"Indications for low-density lipoprotein apheresis","volume":"74","author":"Gordon","year":"1994","journal-title":"Am. J. Cardiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ecl.2015.09.003","article-title":"Lipoprotein Apheresis","volume":"45","author":"Moriarty","year":"2016","journal-title":"Endocrinol. Metab. Clin."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.atherosclerosissup.2012.10.017","article-title":"Lipoprotein apheresis--more than just cholesterol reduction?","volume":"14","author":"Neumann","year":"2013","journal-title":"Atheroscler. Suppl."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cyto.2011.04.003","article-title":"Cytokines profile in serum of homozygous familial hypercholesterolemia is changed by LDL-apheresis","volume":"55","author":"Stefanutti","year":"2011","journal-title":"Cytokine"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/jca.21406","article-title":"Comparison of two low-density lipoprotein apheresis systems in patients with homozygous familial hypercholesterolemia","volume":"31","author":"Tremblay","year":"2016","journal-title":"J. Clin. Apher."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.transci.2015.11.008","article-title":"Severe dyslipidemia in pregnancy: The role of therapeutic apheresis","volume":"53","author":"Russi","year":"2015","journal-title":"Transfus. Apher. Sci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.atherosclerosis.2016.10.018","article-title":"Lipoprotein apheresis is essential for managing pregnancies in patients with homozygous familial hypercholesterolemia: Seven case series and discussion","volume":"254","author":"Ogura","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/1744-9987.13841","article-title":"Pregnancy in homozygous familial hypercholesterolemia\u2014A case series","volume":"26","author":"Blaha","year":"2022","journal-title":"Ther. Apher. Dial."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Marlega-Linert, J., Wartecka-Zielinska, K., Wydra, D., Fijalkowski, M., Gruchala, M., and Mickiewicz, A. (2023). Case report: Lipoprotein apheresis reduces the risk of cardiovascular events and prolongs pregnancy in a woman with severely elevated lipoprotein(a), cardiovascular disease, and a high risk of preeclampsia. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1190446"}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/12\/11\/445\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T13:15:57Z","timestamp":1763471757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/12\/11\/445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,16]]},"references-count":103,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["jcdd12110445"],"URL":"https:\/\/doi.org\/10.3390\/jcdd12110445","relation":{},"ISSN":["2308-3425"],"issn-type":[{"value":"2308-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,16]]}}}